189 related articles for article (PubMed ID: 37004703)
1. Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study.
Jin Y; Zhang R; Jiang J; Liu X
Acta Neurol Belg; 2023 Jun; 123(3):1081-1087. PubMed ID: 37004703
[TBL] [Abstract][Full Text] [Related]
2. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study.
Zhang R; Qiao S; Fang X; Wang K; Shi Y; Du Q; Yang T; Liu X
Front Neurol; 2021; 12():731566. PubMed ID: 34526963
[No Abstract] [Full Text] [Related]
4. Perampanel and lacosamide monotherapy in pediatric patients with newly diagnosed focal epilepsy: A prospective study evaluating efficacy, tolerability, and behavior.
Zhou R; Qu R; Liu M; Huang DP; Zhou JY; Chen Y; Chen XQ
Epilepsy Behav; 2023 Sep; 146():109353. PubMed ID: 37481960
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
6. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial.
Inoue Y; Liao W; Wang X; Du X; Tennigkeit F; Sasamoto H; Osakabe T; Hoshii N; Yuen N; Hong Z
Epilepsy Res; 2021 Oct; 176():106705. PubMed ID: 34246118
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures.
Farkas V; Steinborn B; Flamini JR; Zhang Y; Yuen N; Borghs S; Bozorg A; Daniels T; Martin P; Carney HC; Dimova S; Scheffer IE;
Neurology; 2019 Sep; 93(12):e1212-e1226. PubMed ID: 31462582
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive lacosamide--5 years' clinical experience.
Stephen LJ; Kelly K; Parker P; Brodie MJ
Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region.
Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A
Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial.
Zadeh WW; Escartin A; Byrnes W; Tennigkeit F; Borghs S; Li T; Dedeken P; De Backer M;
Seizure; 2015 Sep; 31():72-9. PubMed ID: 26362380
[TBL] [Abstract][Full Text] [Related]
12. Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open-label exploratory trial.
Auvin S; Arzimanoglou A; Beller C; Floricel F; Daniels T; Bozorg A
Epilepsia; 2023 Nov; 64(11):2947-2957. PubMed ID: 37545406
[TBL] [Abstract][Full Text] [Related]
13. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial.
Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S;
Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101
[TBL] [Abstract][Full Text] [Related]
14. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
Lattanzi S; Trinka E; Zaccara G; Striano P; Russo E; Del Giovane C; Silvestrini M; Brigo F
Drugs; 2022 Feb; 82(2):199-218. PubMed ID: 35061214
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study.
Hong Z; Inoue Y; Liao W; Meng H; Wang X; Wang W; Zhou L; Zhang L; Du X; Tennigkeit F;
Epilepsy Res; 2016 Nov; 127():267-275. PubMed ID: 27669155
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of Lacosamide in pediatric patients with epilepsy under four years: Results from a prospective cohort study in China.
Xiong L; He H; Wang D; Liu T; Xiao N
Seizure; 2024 May; 118():71-79. PubMed ID: 38643678
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study.
Casciato S; Quarato PP; Gialluisi A; D'Aniello A; Mascia A; Grammaldo LG; Di Gennaro G
Epilepsy Behav; 2021 Sep; 122():108128. PubMed ID: 34229159
[TBL] [Abstract][Full Text] [Related]
20. Lacosamide add-on therapy for focal epilepsy.
Babar RK; Bresnahan R; Gillespie CS; Michael BD
Cochrane Database Syst Rev; 2021 May; 5(5):CD008841. PubMed ID: 33998660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]